Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Qual Inq ; 30(2): 175-181, 2024 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-38344057

RESUMO

The rhythmic interplay of accent, tempo, and musical mood is expressed in the bodily postures, gestures, and expressions of attuned responsiveness in Salsa Dura, a genre of salsa music from the 1970s featuring improvisational dance solos. These dancers embrace the feelings and flows of soloing musicians going off and breaking free from any predictable form and structure. We inquire into how world-class salsa dancers and educators feel themselves moved by such intricate rhythms to experience soul connections. Video recordings and interviews yield insight into the call and response dynamics of this essentially tactful practice of alterity.

2.
Am J Ophthalmol Case Rep ; 36: 102124, 2024 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-39156909

RESUMO

Purpose: This case report highlights the importance of monitoring ocular health for patients starting on siponimod treatment, a sphingosine-1-phosphate receptor modulator, for relapsing-remitting multiple sclerosis. By showing how medication adverse events present in patients, we can revisit the current guidelines on ophthalmic evaluation recommendations. Observations: We report a 60-year-old patient who presented with unilateral blurry vision upon initiating siponimod therapy for the treatment of relapsing-remitting multiple sclerosis. Her exam findings did not show visual field defects but were significant for cystoid macular edema distorting the foveal contour. Upon stopping siponimod therapy, the patient's macular edema and symptoms resolved significantly within 7 days and completely resolved 1 month later. Conclusions and importance: This case showcases siponimod-associated cystoid macular edema in a patient without known risk factors, such as diabetes mellitus and uveitis. The patient also had the earliest reported symptom onset to date following the initiation of siponimod therapy. Current recommendations from the American Academy of Ophthalmology and FDA stress the importance of ophthalmic evaluation three to four months after treatment initiation for patients with a history of risk factors. Given our current case and its comparison with four previously reported cases, we recommend that physicians inform patients of possible ocular adverse events with siponimod therapy regardless of their past medical history and duration of treatment.

3.
Nutrients ; 16(11)2024 Jun 05.
Artigo em Inglês | MEDLINE | ID: mdl-38892705

RESUMO

Background: Dietary quality and the consumption of antioxidant-rich foods have been shown to protect against memory decline. Therefore, this double-blind, randomized, placebo-controlled study aimed to investigate the effects of a nutritional supplement on changes in cognitive performance. Methods: In adults aged 40 to 70 years with subjective memory complaints, participants were randomly allocated to take a supplement containing vitamin E, astaxanthin, and grape juice extract daily for 12 weeks or a matching placebo. The primary outcomes comprised changes in cognitive tasks assessing episodic memory, working memory, and verbal memory. Secondary and exploratory measures included changes in the speed of information processing, attention, and self-report measures of memory, stress, and eye and skin health. Moreover, changes in plasma concentrations of brain-derived neurotrophic factor, malondialdehyde, tumor-necrosis factor-α, and interleukin-6 were measured, along with changes in skin carotenoid concentrations. Results: Compared to the placebo, nutritional supplementation was associated with larger improvements in one primary outcome measure comprising episodic memory (p = 0.037), but not for working memory (p = 0.418) or verbal learning (p = 0.841). Findings from secondary and exploratory outcomes demonstrated that the nutraceutical intake was associated with larger improvements in the Everyday Memory Questionnaire (p = 0.022), increased plasma brain-derived neurotrophic factor (p = 0.030), decreased plasma malondialdehyde (p = 0.040), and increased skin carotenoid concentrations (p = 0.006). However, there were no group differences in changes in the remaining outcome measures. Conclusions: Twelve weeks of supplementation with a nutritional supplement was associated with improvements in episodic memory and several biological markers associated with cognitive health. Future research will be essential to extend and validate the current findings.


Assuntos
Fator Neurotrófico Derivado do Encéfalo , Cognição , Suplementos Nutricionais , Humanos , Pessoa de Meia-Idade , Método Duplo-Cego , Masculino , Feminino , Cognição/efeitos dos fármacos , Adulto , Idoso , Fator Neurotrófico Derivado do Encéfalo/sangue , Vitamina E , Xantofilas/administração & dosagem , Pele/efeitos dos fármacos , Antioxidantes , Interleucina-6/sangue , Autorrelato , Carotenoides/sangue , Fator de Necrose Tumoral alfa/sangue , Memória de Curto Prazo/efeitos dos fármacos , Memória Episódica , Sucos de Frutas e Vegetais , Malondialdeído/sangue , Olho/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA